Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Hemorrhagic Fever with Renal Syndrome D006480 3 associated lipids
Venous Thrombosis D020246 11 associated lipids
Mastocytosis D008415 5 associated lipids
Asthenia D001247 5 associated lipids
Chest Pain D002637 4 associated lipids
Purpura, Thrombotic Thrombocytopenic D011697 6 associated lipids
Platelet Storage Pool Deficiency D010981 3 associated lipids
Thrombophilia D019851 6 associated lipids
Carotid Artery Injuries D020212 8 associated lipids
Fistula D005402 8 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Kadiri C et al. Guinea-pig treatment with pertussis toxin suppresses macrophage-dependent bronchoconstriction by fMLP and fails to inhibit the effects of PAF. 1992 Br. J. Pharmacol. pmid:1334747
Fritsche KL and Cassity NA Dietary n-3 fatty acids reduce antibody-dependent cell cytotoxicity and alter eicosanoid release by chicken immune cells. 1992 Poult. Sci. pmid:1333592
Habib A and Maclouf J Comparison of leukotriene A4 metabolism into leukotriene C4 by human platelets and endothelial cells. 1992 Arch. Biochem. Biophys. pmid:1329661
Mori TA et al. Plasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation. 1992 Metab. Clin. Exp. pmid:1328817
Paul-Eugene N et al. Ligation of CD23 triggers cAMP generation and release of inflammatory mediators in human monocytes. 1992 J. Immunol. pmid:1328391
Juergens UR et al. Arachidonic acid metabolism in monocytes of aspirin-sensitive asthmatic patients before and after oral aspirin challenge. 1992 J. Allergy Clin. Immunol. pmid:1328344
Mackenzie R et al. Down-regulation of cyclooxygenase product generation by human peritoneal macrophages. 1992 Immunology pmid:1328041
Conroy DM et al. Vasoactive intestinal peptide and helodermin inhibit the release of cyclo-oxygenase products induced by leukotriene D4 and bradykinin from guinea-pig perfused lung. 1992 Eur. J. Pharmacol. pmid:1327827
Ko FN et al. PAF antagonism in vitro and in vivo by aglafoline from Aglaia elliptifolia Merr. 1992 Eur. J. Pharmacol. pmid:1327822
Rathaus M et al. Altered prostaglandin synthesis and impaired sodium conservation in the kidneys of old rats. 1992 Clin. Sci. pmid:1327646
Chen SC [Plasma renin activity, angiotensin II, angiotensin converting enzyme, thromboxane A2 and prostacyclin I2 levels in pigs with severe hypoxia and hypercapnea and acidosis shock]. 1992 Zhonghua Jie He He Hu Xi Za Zhi pmid:1327548
Landolfi R et al. Increased thromboxane biosynthesis in patients with polycythemia vera: evidence for aspirin-suppressible platelet activation in vivo. 1992 Blood pmid:1327286
Nieminen MM et al. Inhaled budesonide fails to inhibit the PAF-induced increase in plasma leukotriene B4 in man. 1992 Br J Clin Pharmacol pmid:1327049
Coran AG et al. Ibuprofen intervention in canine septic shock: reduction of pathophysiology without decreased cytokines. 1992 J. Surg. Res. pmid:1326683
Mantelli L et al. Effects of thromboxane agonists on cardiac adrenergic neurotransmission. 1992 Eur. J. Pharmacol. pmid:1323473
Winther K et al. Platelet function and fibrinolytic activity in cervical spinal cord injured patients. 1992 Thromb. Res. pmid:1321515
Kumlin M et al. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. 1992 Am. Rev. Respir. Dis. pmid:1320824
Koyama S et al. Dibutyryl cyclic AMP attenuates lung responses induced by endotoxin in conscious sheep. 1992 Am. Rev. Respir. Dis. pmid:1320821
Baker AJ and Fuller RW Effect of cyclic adenosine monophosphate, 5'-(N-ethylcarboxyamido)-adenosine and methylxanthines on the release of thromboxane and lysosomal enzymes from human alveolar macrophages and peripheral blood monocytes in vitro. 1992 Eur. J. Pharmacol. pmid:1319339
Sumner H et al. Inhibition of 5-lipoxygenase and cyclo-oxygenase in leukocytes by feverfew. Involvement of sesquiterpene lactones and other components. 1992 Biochem. Pharmacol. pmid:1319159
Imaizumi A et al. Pertussis toxin induces bronchopulmonary hyperresponsiveness in guinea-pigs while antagonizing the effects of formyl-L-methionyl-L-leucyl-L-phenylalanine. 1992 Eur. J. Pharmacol. pmid:1318209
Chen CX et al. Inhibitory effect of rhynchophylline on platelet aggregation and thrombosis. 1992 Zhongguo Yao Li Xue Bao pmid:1317985
Farrukh IS and Michael JR Cellular mechanisms that control pulmonary vascular tone during hypoxia and normoxia. Possible role of Ca2+ATPases. 1992 Am. Rev. Respir. Dis. pmid:1317692
Longhurst JC et al. Increased concentration of leukotriene B4 but not thromboxane B2 in intestinal lymph of cats during brief ischemia. 1992 Am. J. Physiol. pmid:1317130
Kitsukawa Y et al. Effect of ingestion of eicosapentaenoic acid ethyl ester on carrageenan-induced colitis in guinea pigs. 1992 Gastroenterology pmid:1316857
Rabinovici R et al. Platelet activating factor mediates interleukin-2-induced lung injury in the rat. 1992 J. Clin. Invest. pmid:1314853
Panos RJ et al. Alterations in eicosanoid production by rat alveolar type II cells isolated after silica-induced lung injury. 1992 Am. J. Respir. Cell Mol. Biol. pmid:1312852
Aepfelbacher M et al. Bacterial lipopolysaccharide up-regulates platelet-activating factor-stimulated Ca2+ mobilization and eicosanoid release in human Mono Mac 6 cells. 1992 J. Immunol. pmid:1312103
Martinez GR et al. 3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase. 1992 J. Med. Chem. pmid:1311763
Sata T et al. Paraquat-induced lung injury: prevention by N-tert-butyl-alpha-phenylnitrone, a free-radical spin-trapping agent. 1992 Am. J. Physiol. pmid:1311515
Ryo R et al. Deficiency of P62, a putative collagen receptor, in platelets from a patient with defective collagen-induced platelet aggregation. 1992 Am. J. Hematol. pmid:1311144
Spaethe SM et al. Guinea pig whole blood 5-lipoxygenase assay: utility in the assessment of potential 5-lipoxygenase inhibitors. 1992 Biochem. Pharmacol. pmid:1310855
Yu SM et al. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets. 1992 Biochem. Pharmacol. pmid:1310852
Takashio T et al. Inhibitory effect of pindolol on hypoxic pulmonary vasoconstriction. 1992 Am. J. Physiol. pmid:1310232
Bendele AM et al. Anti-inflammatory activity of BF389, a Di-T-butylphenol, in animal models of arthritis. 1992 J. Pharmacol. Exp. Ther. pmid:1309875
Di Minno G et al. In vivo platelet activation in homozygous cystathionine beta-synthase deficiency: a probucol-sensitive phenomenon. 1992 Trans. Assoc. Am. Physicians pmid:1308991
Jiang K [The study of occurrence mechanism in acute and chronic cerebral vasospasm]. 1992 Zhonghua Shen Jing Jing Shen Ke Za Zhi pmid:1304997
Taylor BJ et al. Effects of alveolar hypoxia on the pulmonary circulation and lung mechanics after cromolyn sodium and U-60,257 in lambs. 1992 J. Dev. Physiol. pmid:1304007
Jiang HW et al. [Clinical study in treating qi-deficiency and blood-stasis syndrome of angina pectoris with qi xue granule]. 1992 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:1301847
Bassalyk LS et al. [The effect of indomethacin and leukinferon on the thromboxane B2 level in the blood plasma of patients with endometrial cancer in the perioperative period]. 1992 Vopr Onkol pmid:1300754
Chantharaksri U et al. Pathogenesis of hypoxemia. 1992 Southeast Asian J. Trop. Med. Public Health pmid:1298990
Liu H et al. Clinical implication of the changes of cAMP, TXA2 and PGI2 in CSF of asphyxiated newborns. 2003 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:12973949
Dionne RA et al. Dexamethasone suppresses peripheral prostanoid levels without analgesia in a clinical model of acute inflammation. 2003 J. Oral Maxillofac. Surg. pmid:12966473
Cerletti C et al. Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes. 2003 Clin Pharmacokinet pmid:12959636
Tanigawa T et al. Anti-inflammatory effect of two isoforms of COX in H. pylori-induced gastritis in mice: possible involvement of PGE2. 2004 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12958020
Chen HI et al. Effects of acute exercise on the biosynthesis of eicosanoids in rats. 1992 Chin J Physiol pmid:1295717
Seebacher F and Franklin CE Prostaglandins are important in thermoregulation of a reptile (Pogona vitticeps). 2003 Proc. Biol. Sci. pmid:12952634
Wu X et al. Zileuton, a 5-lipoxygenase inhibitor, increases production of thromboxane A2 and platelet aggregation in patients with asthma. 2003 Am. J. Hematol. pmid:12949886
Tsipas G and Morphake P Beneficial effects of a diet rich in a mixture of n - 6/n - 3 essential fatty acids and of their metabolites on cyclosporine - nephrotoxicity. 2003 J. Nutr. Biochem. pmid:12948879
Al-Waili NS and Boni NS Natural honey lowers plasma prostaglandin concentrations in normal individuals. 2003 J Med Food pmid:12935324
Zhuang HP et al. [Effect of aspirin combined with perindopril on prostacyclin, thromboxone A2, and norepinephrine in the blood of arteriosclerosis rabbit models and the cardiac function]. 2003 Hunan Yi Ke Da Xue Xue Bao pmid:12934393
Yu CC and Lai YL Chronic hypoxia attenuates ischemia-reperfusion-induced increase in pulmonary vascular resistance. 2003 Life Sci. pmid:12927588
Jörres A et al. Thromboxane B2 urinary metabolites in patients undergoing cardiopulmonary bypass. 1992 Eicosanoids pmid:1292525
Tomita Y et al. Melanocyte-stimulating properties of arachidonic acid metabolites: possible role in postinflammatory pigmentation. 1992 Pigment Cell Res. pmid:1292020
OuYang WX [Mechanism and effect of anisodamine on uteroplacental circulation in pregnancy-induced hypertension]. 1992 Zhonghua Fu Chan Ke Za Zhi pmid:1291219
Patrono C Aspirin resistance: definition, mechanisms and clinical read-outs. 2003 J. Thromb. Haemost. pmid:12911581
Shimada N et al. Increased endothelin: nitric oxide ratio is associated with erythropoietin-induced hypertension in hemodialysis patients. 2003 Ren Fail pmid:12911161
Pestel S et al. Inhibition of prostaglandin D2 clearance in rat hepatocytes by the thromboxane receptor antagonists daltroban and ifetroban and the thromboxane synthase inhibitor furegrelate. 2003 Biochem. Pharmacol. pmid:12906929
Dapper F et al. Effects of pulsatile and nonpulsatile perfusion mode during extracorporeal circulation--a comparative clinical study. 1992 Thorac Cardiovasc Surg pmid:1290181
Montalescot G et al. Lack of platelet-activating factor release during reversible myocardial ischaemia. 1992 Eur. Heart J. pmid:1289094
Villalobos MA et al. Effects of camonagrel, a selective inhibitor of platelet thromboxane synthase, on the platelet-subendothelium interaction. 2003 Pharmacology pmid:12886030
Wolfram R et al. Daily prickly pear consumption improves platelet function. 2003 Prostaglandins Leukot. Essent. Fatty Acids pmid:12878452
De Cristofaro R et al. Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus. 2003 J. Thromb. Haemost. pmid:12871497
Heller AR et al. Clusterin protects the lung from leukocyte-induced injury. 2003 Shock pmid:12865662
Miceli M et al. Effect of low doses of ethanol on platelet function in long-life abstainers and moderate-wine drinkers. 2003 Life Sci. pmid:12865095
Pettus BJ et al. Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release. 2003 J. Biol. Chem. pmid:12855693
Desquand S et al. Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection. 1991 Br. J. Pharmacol. pmid:1285397
Castellani S et al. Thromboxane inhibition improves renal perfusion and excretory function in severe congestive heart failure. 2003 J. Am. Coll. Cardiol. pmid:12849673
Ziser A et al. Propofol does not induce pulmonary dysfunction in stressed endotoxic pigs receiving Intralipid. 2003 Crit. Care Med. pmid:12847400
Li S et al. [The experimental investigation on the preventive effects of API0134 against the re-occlusion of coronary arteries after therapeutic thrombolysis in dogs]. 1999 J. Tongji Med. Univ. pmid:12840851
Reid G et al. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12835412
Montuschi P et al. Exhaled leukotrienes and prostaglandins in COPD. 2003 Thorax pmid:12832671
Bode-Böger SM et al. Endothelin release and shift in prostaglandin balance are involved in the modulation of vascular tone by recombinant erythropoietin. 1992 J. Cardiovasc. Pharmacol. pmid:1282978
Patrignani P et al. Release of contracting autacoids by aortae of normal and atherosclerotic rabbits. 1992 J. Cardiovasc. Pharmacol. pmid:1282972
Sartin JL et al. Estradiol plus progesterone treatment modulates select elements of the proinflammatory cytokine cascade in steers: attenuated nitric oxide and thromboxane B2 production in endotoxemia. 2003 J. Anim. Sci. pmid:12817503
Brunelleschi S et al. Enhanced responsiveness of ovalbumin-sensitized guinea-pig alveolar macrophages to tachykinins. 1992 Br. J. Pharmacol. pmid:1281723
Guyton K et al. Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli. 2003 Shock pmid:12813370
Davì G et al. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 2003 Circulation pmid:12810609
Park WH et al. The antiplatelet activity of Geiji-Bokryung-Hwan, Korean traditional formulation, is mediated through inhibition of phospholipase C and inhibition of TxB(2) synthetase activity. 2003 Int. Immunopharmacol. pmid:12810354
Rünzi M et al. Importance of endogenous prostaglandins for the toxicity of cyclosporin A to rat endocrine and exocrine pancreas? 1992 Gut pmid:1280611
De La Cruz JP et al. Differences in the effects of extended-release aspirin and plain-formulated aspirin on prostanoids and nitric oxide in healthy volunteers. 2003 Fundam Clin Pharmacol pmid:12803576
Mohan CR et al. Does iloprost mediate thromboxane activity and polymorphonuclear leukocyte sequestration in ischemic skeletal muscle? 1992 Sep-Oct J Cardiovasc Surg (Torino) pmid:1280271
von Aulock S et al. Determination of the eicosanoid response to inflammatory stimuli in whole blood and its pharmacological modulation ex vivo. 2003 J. Immunol. Methods pmid:12799039
Meune C et al. Aspirin alters arterial function in patients with chronic heart failure treated with ACE inhibitors: a dose-mediated deleterious effect. 2003 Eur. J. Heart Fail. pmid:12798824
Mentz P et al. Interactions of prostanoids with the platelet activating factors. 1992 Prostaglandins Leukot. Essent. Fatty Acids pmid:1279731
Devillier P et al. Activation of an epithelial neurokinin NK-1 receptor induces relaxation of rat trachea through release of prostaglandin E2. 1992 J. Pharmacol. Exp. Ther. pmid:1279160
Machin KL et al. Pharmacodynamics of flunixin and ketoprofen in mallard ducks (Anas platyrhynchos). 2001 J. Zoo Wildl. Med. pmid:12790425
Fujimoto Y et al. Effects of endocrine disruptors on arachidonic acid metabolism in rabbit platelets. 2003 Toxicol. Appl. Pharmacol. pmid:12781627
Yregård L et al. Influence of local anaesthetics on inflammatory activity postburn. 2003 Burns pmid:12781610
Ojanen R et al. Single dose of acetylsalicylic acid prevents thromboxane release after tourniquet ischemia. 2003 J Trauma pmid:12777914
Li ZG et al. [Progress on study of experimental physico-chemical indexes related with ischemic stroke]. 2003 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:12764922
Huang RJ et al. [Effect of tetramethylpyrazine on endothelin, von Willebrand factor and thromboxane A2 during cardiopulmonary bypass in patients of congenital heart disease with pulmonary hypertension]. 2003 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:12764908
Lang I et al. Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells. 2003 Eur. J. Cell Biol. pmid:12751902
Leese PT et al. The COX-2 selective inhibitor, valdecoxib, does not impair platelet function in the elderly: results of a randomized controlled trial. 2003 J Clin Pharmacol pmid:12751271
Hart RG et al. Aspirin dosage and thromboxane synthesis in patients with vascular disease. 2003 Pharmacotherapy pmid:12741431
Tuleja E et al. Effects of cyclooxygenases inhibitors on vasoactive prostanoids and thrombin generation at the site of microvascular injury in healthy men. 2003 Arterioscler. Thromb. Vasc. Biol. pmid:12730088
Chavarría ME et al. Prostacyclin/thromboxane early changes in pregnancies that are complicated by preeclampsia. 2003 Am. J. Obstet. Gynecol. pmid:12712098
Molina V et al. Synergistic effect of D-003 and aspirin on experimental thrombosis models. 2003 Prostaglandins Leukot. Essent. Fatty Acids pmid:12711246
Ferlito M et al. Implication of Galpha i proteins and Src tyrosine kinases in endotoxin-induced signal transduction events and mediator production. 2002 J. Endotoxin Res. pmid:12701623
Pfeiffer S et al. Hyperacute lung rejection in the pig-to-human model. III. Platelet receptor inhibitors synergistically modulate complement activation and lung injury. 2003 Transplantation pmid:12698079